By clicking “Subscribe” you agree to our Terms and Conditions and Privacy Policy.
Testosterone replacement therapy has an image problem. For many people, TRT conjures images of bodybuilders, steroid abuse, and health risks. The reality is far more nuanced — and far more clinical.
TRT is a legitimate, well-studied medical treatment for men with clinically low or suboptimal testosterone levels. When properly prescribed and monitored, it restores testosterone to physiological levels — not supraphysiological ones. The goal isn’t to create artificially elevated testosterone; it’s to restore what time and biology have taken away.
Luvo’s testosterone program offers TRT as one component of a comprehensive hormone optimization approach, paired with clinical monitoring and complementary medications like Enclomiphene and Gonadorelin when appropriate.
Testosterone replacement therapy introduces exogenous (externally sourced) testosterone into the body, raising blood testosterone levels to a target range determined by your provider. The testosterone used in TRT is bioidentical — chemically identical to the testosterone your body produces naturally.
Once administered, exogenous testosterone enters the bloodstream and binds to androgen receptors throughout the body. These receptors are found in muscle tissue (stimulating protein synthesis and muscle growth), bone cells (supporting bone density and mineralization), the brain (influencing mood, cognition, and motivation), fat tissue (promoting lipolysis and reducing fat storage), reproductive organs (supporting libido and sexual function), and red blood cell precursors (stimulating erythropoiesis).
The effects of TRT develop over different timescales. Improvements in energy, mood, and libido often appear within 3–6 weeks. Body composition changes — increased muscle mass and decreased body fat — typically become noticeable over 3–6 months. Bone density improvements may take 12 months or longer to manifest.
TRT is appropriate for men with documented low or suboptimal testosterone levels confirmed by blood work, along with symptoms consistent with testosterone deficiency. Ideal candidates typically include men with total testosterone consistently below 300–400 ng/dL, men with symptoms of low T despite levels in the low-normal range of 300–500 ng/dL, men who have ruled out or addressed reversible causes such as sleep apnea, obesity, and medication effects, and men without contraindications including untreated prostate cancer, severe untreated sleep apnea, or uncontrolled heart failure.
TRT is generally not recommended as a first-line treatment for younger men who wish to preserve fertility, since exogenous testosterone suppresses the HPG axis and can significantly reduce sperm production. For these men, Luvo offers Enclomiphene and Gonadorelin as alternatives or adjuncts.
Luvo’s providers conduct thorough bloodwork and clinical evaluation before prescribing TRT, ensuring it’s the right intervention for your specific situation.
The benefits of properly administered TRT are well-documented across multiple domains.
Body composition improves significantly. Meta-analyses show that TRT produces an average increase in lean body mass of 3–5 pounds and a decrease in fat mass of 3–4 pounds over 6–12 months, even without changes to diet or exercise. When combined with resistance training and proper nutrition, the improvements are substantially greater.
Sexual function responds reliably to testosterone optimization. Libido, erectile function, and sexual satisfaction all improve in men with low baseline testosterone. TRT doesn’t replace treatments for ED caused by vascular or neurological factors, but when low T is a contributing cause, the improvement can be dramatic.
Mood, cognition, and energy are among the earliest and most appreciated benefits. Men frequently describe feeling like themselves again — more motivated, more mentally sharp, and more emotionally stable. Clinical studies support reductions in depressive symptoms and improvements in verbal memory and spatial reasoning.
Bone density increases over 12–24 months, reducing fracture risk — an increasingly important concern as men age.
Metabolic health markers often improve, including insulin sensitivity, lipid profiles, and inflammatory markers. Some research suggests TRT may reduce the risk of metabolic syndrome and Type 2 diabetes in men with low testosterone.
TRT is not risk-free, and responsible prescribing requires ongoing monitoring. This is where Luvo’s program differs significantly from competitors who may offer TRT with minimal follow-up.
Erythrocytosis (elevated red blood cell count) is the most common side effect of TRT, occurring because testosterone stimulates red blood cell production. If unchecked, this can increase blood viscosity and cardiovascular risk. Luvo monitors hematocrit levels regularly and adjusts dosing or recommends blood donation if levels rise too high.
Testicular suppression occurs because exogenous testosterone signals the pituitary to reduce LH and FSH production, which can cause testicular atrophy and reduced sperm production. Luvo addresses this proactively with Gonadorelin, which maintains gonadotropin signaling and testicular function alongside TRT.
Estrogen conversion can occur as some testosterone is converted to estradiol by the aromatase enzyme. Symptoms of elevated estrogen include water retention, mood changes, and gynecomastia. Luvo monitors estradiol levels and can adjust protocols accordingly.
Regular bloodwork — including total and free testosterone, estradiol, hematocrit, PSA, and metabolic panels — is a non-negotiable part of Luvo’s TRT program. This level of monitoring is what separates responsible hormone optimization from reckless prescribing.
Learn more about Luvo’s testosterone medication and the full testosterone program.
Testosterone is the most important androgen in the male body. It drives hormonal balance, bone density, red blood cell production, fat distribution, libido, mood, cognitive function, and energy. It's not an exaggeration to say that testosterone influences virtually every system in a man's body.
And yet, when testosterone levels decline — as they do in nearly every man starting around age 30 — most men don't recognize what's happening. They chalk up the fatigue to stress, the weight gain to aging, the low libido to being busy. By the time many men seek help, they've been living with suboptimal testosterone for years.
Luvo's testosterone program is designed to change that. With three distinct medication options — testosterone replacement, Enclomiphene, and Gonadorelin — and clinical oversight from providers who specialize in male hormone optimization, Luvo offers a personalized approach that goes far beyond a simple testosterone prescription.
Clinically, low testosterone (hypogonadism) is generally defined as a total testosterone level below 300 ng/dL, though many experts argue that symptoms can appear at levels well above this cutoff. The reference range for total testosterone is typically 300–1,000 ng/dL, but a man at 350 ng/dL may feel dramatically different from a man at 700 ng/dL — even though both are technically "normal."
This is an important nuance that many healthcare providers miss. Standard medicine treats low testosterone as a binary — you're either below 300 and qualify for treatment, or you're above 300 and told you're fine. Luvo's program recognizes that optimization matters. Feeling "normal" isn't the goal — feeling your best is.
Testosterone levels decline approximately 1–2% per year after age 30. By 45, many men have lost 20–30% of their peak testosterone. By 60, that number can exceed 40%. This gradual decline — sometimes called andropause — is a natural process, but its effects are anything but trivial.
Low testosterone manifests across physical, mental, and sexual domains, and the symptoms often develop so gradually that men adapt to them without realizing what's changed.
Physical symptoms include persistent fatigue and low energy even with adequate sleep, increased body fat particularly around the midsection, reduced physical vitality and endogenous testosterone support, reduced bone density, and hair thinning beyond normal male-pattern baldness.
Mental and emotional symptoms include brain fog and difficulty concentrating, irritability and mood swings, depression or persistent low mood, reduced motivation and drive, and poor sleep quality or insomnia.
Sexual symptoms include decreased libido, erectile dysfunction or reduced quality of erections, and reduced sexual satisfaction.
If you're experiencing several of these symptoms, declining testosterone may be a contributing factor. Luvo's program begins with a thorough clinical evaluation to determine whether testosterone optimization is appropriate for you.
Age-related decline is the most common cause, but it's not the only factor. Several lifestyle and medical conditions can accelerate testosterone loss.
Obesity is one of the strongest modifiable risk factors. Fat tissue contains aromatase, an enzyme that converts testosterone to estrogen. The more body fat you carry, the more testosterone you lose to conversion. This creates a vicious cycle: low testosterone promotes fat gain, and fat gain further reduces testosterone.
Chronic stress elevates cortisol, which directly suppresses testosterone production. The hypothalamic-pituitary-gonadal (HPG) axis — the hormonal cascade that controls testosterone — is highly sensitive to cortisol interference.
Poor sleep is devastatingly effective at lowering testosterone. Studies show that sleeping only 5 hours per night for one week can reduce testosterone levels by 10–15%. Sleep is when the majority of daily testosterone production occurs.
Other contributing factors include excessive alcohol consumption, certain medications including opioids and some antidepressants, metabolic syndrome and insulin resistance, and environmental endocrine disruptors.
Luvo's providers assess these factors during your consultation, because effective treatment addresses root causes alongside hormone optimization.
What distinguishes Luvo's testosterone program from competitors like Hims, Remedy Meds, or OrderlyMeds is the range of treatment options and the clinical sophistication behind the prescribing.
Testosterone replacement therapy (TRT) directly supplements testosterone levels, restoring them to an optimal range. It's the most direct and potent option for men with clearly low levels.
Enclomiphene is a selective estrogen receptor modulator (SERM) that stimulates the body's own endogenous testosterone support by blocking estrogen's negative feedback on the pituitary gland. It's particularly valuable for men who want to boost testosterone while preserving fertility.
Gonadorelin is a GnRH (gonadotropin-releasing hormone) analog that provides HPG axis support and maintains testicular function and fertility preservation during testosterone therapy. It's often used alongside TRT to prevent the testicular suppression that exogenous testosterone can cause.
These three medications can be used individually or in strategic combinations, giving Luvo's providers the flexibility to design a protocol tailored to your specific hormonal profile, symptoms, and life goals. Explore each option: testosterone medication, Enclomiphene, and Gonadorelin.
If your GLP-1 or GLP-1/GIP medication is provided in a vial (rather than a prefilled pen), accurate measurement is critical. Many injection-related problems are not “medication failures,” but simple measurement errors that can increase side effects and risk.
This guide is not a substitute for your prescription label. Always follow your clinician’s specific dosing instructions.
Know the three measurement concepts
Your prescription and pharmacy label should connect these safely (for example, dose in mg + the corresponding syringe units for your specific concentration). If you don’t see that mapping, stop and contact your clinician or pharmacy before injecting.
If you miss a dose, do not “double” to catch up. Contact your care team for instructions based on your prescription.
Severe or persistent vomiting, signs of dehydration, severe abdominal pain, or any symptom that feels abnormal warrants medical attention.
A GLP-1 plateau can feel discouraging, but it’s often a normal checkpoint, not a failure.
As weight decreases, your body adapts. Energy needs can change, and routines that worked early may become less effective. Plateaus can also reflect inconsistent nutrition (especially protein), reduced movement, stress, or sleep disruption.
Treat a plateau like feedback. It’s telling you what needs refinement: habits, support, expectations, or clinical oversight.
GLP-1 medications don’t “work” in a single moment—most people experience a timeline of changes.
Many patients notice appetite shifts first: feeling full sooner, less snacking, fewer cravings. Side effects can also appear early, especially nausea or constipation.
Sustainable weight change usually requires consistent use plus lifestyle structure. During this phase, nutrition strategy matters: protein, fiber, hydration, and routines that reduce decision fatigue.
Weight loss is rarely linear. Plateaus are predictable. A plateau often means you need an adjustment in habits, clinical strategy, or expectations—not that “it stopped working.”
Not the scale week-to-week, but the system you can sustain: meals you repeat, movement you can maintain, and a care team you can reach if something feels off.
If you have severe side effects, dehydration symptoms, or you’re considering changing dose timing or amounts, contact your clinician. Do not self-adjust, especially if your medication requires measuring doses.
If you’re thinking about stopping semaglutide, the most important step is simple: talk to your clinician first. Stopping weight-management medication is a medical decision, not just a “break.”
People don’t typically describe “withdrawal” the way they would with certain other drug classes. But many notice changes after stopping: appetite may increase, cravings may return, and weight regain can be common without a structured maintenance plan.
Semaglutide supports satiety and appetite regulation. When you remove that support, your body can return toward previous appetite patterns—especially if lifestyle habits aren’t yet stable.
If you have severe symptoms or you’re stopping due to side effects, contact your clinician promptly to discuss safer alternatives or symptom management.
If you’re not losing weight on semaglutide, the situation is usually solvable—but it requires a structured review rather than guesswork. Weight loss can stall for reasons that have nothing to do with “willpower.”
If you’re stalled, a clinician can evaluate whether the plan needs adjustment and screen for issues that require medical attention. Avoid self-adjusting dosing.
Feeling hunger on semaglutide can be frustrating—especially if you expected “no appetite at all.” In reality, most people still feel some hunger. The goal is often less impulsive hunger and better control.
If hunger stays intense for weeks, you’re gaining weight unexpectedly, or side effects are severe, contact your clinician. Do not self-adjust dosing.
If you’re still hungry on tirzepatide, it doesn’t automatically mean treatment “isn’t working.” Hunger can change week to week, and several fixable factors may be involved.
If hunger remains high for multiple weeks, or weight and appetite trends move in an unexpected direction, contact your care team. Dose adjustments and plan changes require clinician oversight—do not self-adjust.
Constipation is a common complaint when appetite drops and digestion slows. If constipation shows up during semaglutide therapy, you can often improve it with a few structured habits—without extreme changes.
Low fluid intake is a frequent cause. Sip water consistently, and consider warm liquids (tea or broth) if tolerated.
Fiber helps, but a sudden jump in high-fiber foods can worsen bloating. Increase fiber gradually through cooked vegetables, oats, berries, beans, or fiber supplements only if your clinician approves.
Even light walking can support bowel motility. Consistency matters more than intensity.
If you’re eating very little, bowel movements may slow. Focus on small, regular meals that include protein and gentle fiber.
Severe abdominal pain, blood in stool, persistent constipation, or inability to pass gas warrants medical evaluation. Don’t ignore severe symptoms.
Nausea is one of the most common early side effects people report on semaglutide-based therapy. The good news: for many patients, it improves as the body adjusts—especially when you use a few practical habits.
Eat smaller meals, slow down, and stop at “comfortably satisfied.” Overeating can feel worse when digestion is slower.
Dehydration can worsen nausea and fatigue. Sip water throughout the day. If your clinician recommends electrolytes, use them strategically.
Many people tolerate bland, protein-forward foods better during the adjustment phase: yogurt, eggs, soups, cooked vegetables, toast, rice, or smoothies (if tolerated).
Very fatty meals, fried foods, and heavy desserts can worsen nausea in some people. If symptoms spike after certain foods, reduce them temporarily.
Some patients find nausea is more noticeable in a predictable window after dosing. Keep meals lighter during that window and avoid large, rich meals.
Severe or persistent vomiting, inability to keep fluids down, or signs of dehydration require medical attention. Don’t self-adjust treatment without clinician input.
There isn’t a universal “forbidden foods” list for semaglutide. But because semaglutide can slow digestion, certain foods are more likely to trigger discomfort—especially early in treatment.
Think “gentle, small, steady.” Many people do better with smaller meals, eaten more slowly, emphasizing protein and easy-to-digest fiber.
The most useful approach is a short “food journal”: what you ate, portion size, timing, and symptoms. This helps you personalize choices rather than following overly strict lists.
If you cannot keep fluids down, have signs of dehydration, or symptoms are severe or persistent, reach out to your care team. Don’t self-adjust dosing.
